DD293352A5 - PROCESS FOR PREPARING 2,2-DISUBSTITUTED 1-ACYL AND / OR 9-ACYL-2,3-DIHYDRO-IMIDAZO / 1,2-A / BENZIMIDAZOLE-3-ONEN - Google Patents
PROCESS FOR PREPARING 2,2-DISUBSTITUTED 1-ACYL AND / OR 9-ACYL-2,3-DIHYDRO-IMIDAZO / 1,2-A / BENZIMIDAZOLE-3-ONEN Download PDFInfo
- Publication number
- DD293352A5 DD293352A5 DD33950390A DD33950390A DD293352A5 DD 293352 A5 DD293352 A5 DD 293352A5 DD 33950390 A DD33950390 A DD 33950390A DD 33950390 A DD33950390 A DD 33950390A DD 293352 A5 DD293352 A5 DD 293352A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- acyl
- disubstituted
- dihydro
- imidazo
- acid
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Die Erfindung betrifft ein Verfahren zur Herstellung von neuen 2,2-disubstituierten 1-Acyl- und/oder * die erfindungsgemaesz durch Umsetzung von 2,2-disubstituierten * mit einem Arylierungs-/Acylierungsmittel wie Saeurechlorid oder Cyansaeureester in Gegenwart eines saeurebindenden Mittels oder in einem aprotischen Loesungsmittel bei Temperaturen von 100 bis 200C erhalten werden. Die neuen Verbindungen sind fuer biozide Mittel, insbesondere Herbizide, Akarizide, Insektizide, Fungizide und Anthelmintika, verwendbar.{disubstituiertes * disubstituiertes * Acylierung; Saeurechlorid; Kohlensaeure-ester-chlorid; Thiokohlensaeure-O-ester-chlorid; Cyansaeureester; Isocyansaeureester; aprotisches Loesungsmittel; thermische Isomerisierung}The invention relates to a process for the preparation of novel 2,2-disubstituted 1-acyl and / or the invention by reacting 2,2-disubstituted * with an arylating / acylating agent such as acid chloride or cyanate in the presence of an acid-binding agent or in an aprotic solvent at temperatures of 100 to 200C. The new compounds are useful for biocides, especially herbicides, acaricides, insecticides, fungicides and anthelmintics. {Disubstituted * disubstituted * acylation; acid chloride; Carbonic acid ester chloride; Thiocarbonic acid O-ester chloride; cyanate ester; isocyanic; aprotic solvent; thermal isomerization}
Description
Hierzu 1 Seite FormelnFor this 1 page formulas
Anwendungsgebiet der ErfindungField of application of the invention
Die Erfindung betrifft ein Verfahren zur selektiven Herstellung von neuen 2,2-dlsubstltulerten 1 -Acyl- und/oder 9-Acyl-2,3-dihydro-imidazol1,2-albenzimidazol-3-onen, die als Wirkstoffe für biozide Mittel, insbesondere als Herbizide, Akarizlde, Insektizide, Fungizide und Anthelmintika, von Interesse sein können.The invention relates to a process for the selective preparation of novel 2,2-dlsubstltulerten 1-acyl and / or 9-acyl-2,3-dihydro-imidazol1,2-albenzimidazol-3-ones, which are used as active ingredients for biocidal agents, in particular as herbicides, acaricides, insecticides, fungicides and anthelmintics may be of interest.
Es ist bekannt, daß Acyldorivate von 1,3,5,-Triazino[1,2-a]-benzlmidazolen sehr gute herbizide (D. MARTIN, H. GRAUBAUM, J.prakt.Chem.321,315 (1979), DD-PS 242340, DD-PS 227035, DE-OS 2144505, US-PS 4497650), fungizide (DE-OS 2527677) und insektizide (DD-PS 235019) Eigenschaften besitzen. Außerdem sind auch pharmakologische Eigenschaften derTriazino[1,2-albenzimidazole gegen Nematoden, Zutoden und Hakenwürmer (DE-OS 2452365, GB-PS 1522076) bekannt. Acylderivate der lmidazo|1,2-a]benzimidazole sind bishör noch nicht beschrieben. Lediglich die 9-Aryl-2,3-dihydro-imidazo[1,2-ajbenzimldazole sind mit pharmakologischon Eigenschaften In der Literatur (GB-PS 1476949) zitiert. Des weiteren ist das 2,2-Diphenyl-2,3-dihydro-imidazol1,2-a]benzimidazol-3-on durch Thermolyse von 1-Aryl-2-cyano-3,3-diphenyl-diazetidin-4-on darstellbar (CW.BIRD, M.W.KACZMAR, C.K.WONG: Tetrahedron 30,2549 (19741). Die als Ausgangsprodukte benötigten 2,2-disubstituierten 2,3-Dihydro-imidazo[1,2-a]benzimidazol-3-one wurden aus 2-Amino-benzimidazol, Chloroform und Aceton bzw. Cyclohexanon und anschließender Cyclisierung mit Thionylchlorid (H.GRAUBAUM, R.OZEGOWSKI: J.prakt.Chem.: in Vorbereitung) nach bekannten Verfahren hergestellt.It is known that acyldorivatives of 1,3,5-triazino [1,2-a] -benzimidazoles are very good herbicides (D. MARTIN, H. GRAUBAUM, J.prakt.Chem.321,315 (1979), DD-PS 242340, DD-PS 227035, DE-OS 2144505, US-PS 4497650), fungicidal (DE-OS 2527677) and insecticidal (DD-PS 235019) properties. In addition, pharmacological properties of the triazino [1,2-albenzimidazoles against nematodes, clades and hookworms (DE-OS 2,452,365, GB-PS 1522076) are also known. Acyl derivatives of imidazo | 1,2-a] benzimidazoles have not yet been described. Only the 9-aryl-2,3-dihydro-imidazo [1,2-ajbenzimldazole are cited with pharmacological properties in the literature (GB-PS 1476949). Furthermore, the 2,2-diphenyl-2,3-dihydro-imidazol1,2-a] benzimidazol-3-one can be prepared by thermolysis of 1-aryl-2-cyano-3,3-diphenyl-diazetidin-4-one (CW.BIRD, MWKACZMAR, CKWONG: Tetrahedron 30, 2549 (19741).) The 2,2-disubstituted 2,3-dihydroimidazo [1,2-a] benzimidazol-3-ones required as starting materials were obtained from 2 -Amino-benzimidazole, chloroform and acetone or cyclohexanone and subsequent cyclization with thionyl chloride (H.GRAUBAUM, R.OZEGOWSKI: J.prakt. Chem: in preparation) prepared by known methods.
Es ist das Ziel der Erfindung, ein selektives Verfahren zur Herstellung von neuen 2,2-disubsituierten 1 -Acyl- und/oder 9-Acyl-2,3-dihydro-imidazo(1,2-a]benzimidazol-3-onen zu entwickeln, das keine komplizierten Verfahrens- oder Trennschritte erfordert und durch das eine Vielzahl von Verbindungen mit unterschiedlichen Substituentenmustern zugänglich wird.It is the object of the invention to provide a selective process for the preparation of novel 2,2-disubstituted 1-acyl and / or 9-acyl-2,3-dihydroimidazo (1,2-a) benzimidazol-3-ones which does not require complicated process or separation steps and which makes a variety of compounds having different substituent patterns available.
Aufgabe der Erfindung ist es, durch Acylierung von 2,2-disubstituierten 1 (9)-H-2,3-Dihydro-imidazol1,2-a]benzimidazol-3-onen das Ziel der Erfindung erreichen.The object of the invention is to achieve the object of the invention by acylation of 2,2-disubstituted 1 (9) -H-2,3-dihydro-imidazol1,2-a] benzimidazol-3-ones.
Diese Aufgabe wird gelöst durch ein Verfahren zur Herstellung neuer 2,2-disubstituierter 1-Acyl- oder 9-Acyl-2,3-dihydroimidazo(1,2-a]benzimidazol-3-one der allgemeinen Formel 3 bzw. 2,This object is achieved by a process for the preparation of novel 2,2-disubstituted 1-acyl or 9-acyl-2,3-dihydroimidazo (1,2-a) benzimidazol-3-ones of the general formula 3 or 2,
7»7 »
in der bedeuten: —in which mean: -
R, R': jeweils Methyl oder gemeinsam Pentamethylen,R, R ': in each case methyl or together pentamethylene,
Acyl: COR', COOR2, C(=NH)OR2, CONHR2 oder CI=S)OR2, wobei R2 Alkyl oder gegebenenfallsAcyl: COR ', COOR 2 , C (= NH) OR 2 , CONHR 2 or CI = S) OR 2 , where R 2 is alkyl or optionally
substituiertes Aryl sein kann,may be substituted aryl,
indem man erfindungsgemäß ein Säurechlorid der allgemeinen Formel R2COCI, ein Kohlensäure-ester-chlorid der allgemeinen Formel R2COOCI, ein Cyansäureester der allgemeinen Formel R2OCN, ein Isocyansäureester R2NCO oder ein Thiokohlensäureester-Ö-ester-chlorid der allgemeinen Formel R2OCSCI mit einem 2,2-disubstituierten 2,3-Dihydro-imidazo[1,2-a]benzimidazol 1, bei der R und R1 die oben genannten Bedeutungen haben, bei Temperaturen von -10O0C bis +2000C umsetzt.by according to the invention an acid chloride of the general formula R 2 COCI, a carbonic acid ester chloride of the general formula R 2 COOCI, a cyanic acid ester of the general formula R 2 OCN, an isocyanic ester R 2 NCO or a Thiokohlensäureester-Ö-ester chloride of the general Formula R 2 OCSCI with a 2,2-disubstituted 2,3-dihydro-imidazo [1,2-a] benzimidazole 1 in which R and R 1 have the abovementioned meanings, at temperatures from -10O 0 C to +200 0 C converts.
In Abhängigkeit vom Aryl rest und von der Reaktionstemperatur entstehen dabei selektiv die 1-Acy !derivate 3 oder die isomeren 9-Acylderivate 2. Die bei Temperaturen von -1000C bis 50°C entstehenden Verbindungen 2 lassen sich thermisch bei Temperaturen von 1O0C bis 2000C mit und ohne Lösungsmittel zu 3 isomerisieren, wobei als Lösungsmittel zum Beispiel Acetonitril, Dioxan, DMF, DMSO oder Pyridin verwendet werden kann.Depending on the aryl radical and originate from the reaction temperature, thereby selectively 1-acylphenylalanine derivatives 3 or the isomeric 9-acyl derivatives 2. The compounds 2 formed at temperatures from -100 0 C to 50 ° C can be thermally at temperatures of from 1O 0 C to 200 0 C with and without solvent isomerize to 3, wherein as a solvent, for example, acetonitrile, dioxane, DMF, DMSO or pyridine can be used.
Es lassen sich auch die Verbindungen 3 direkt aus 1 und dem entsprechenden Acylierungsmittel darstellen, ohne Isolierung der isomeren Verbindungen 2 (siehe Beispiel 4). Bei der Reaktion von 1 mit Cyansäureestern und Isocyansäureestern (Methode A) wird erfindungsgemäß in einem aprotischen Lösungsmittel gearbeitet, bei der Umsetzung mit Säurechloriden, Kohlensäureester-chloriden oder Thiokohlensäure-O-ester-chloriden ist ein säurebindendes Mittel, z. B. Triethylamin, Na2CO3 oder Pyridin, vorteilhaft (Methode B).It can also be the compounds 3 directly from 1 and the corresponding acylating agent, without isolation of the isomeric compounds 2 (see Example 4). In the reaction of 1 with cyanic acid esters and isocyanic acid esters (Method A) is carried out according to the invention in an aprotic solvent, in the reaction with acid chlorides, carbonic acid ester chlorides or thiocarbonic O-ester chlorides is an acid-binding agent, eg. As triethylamine, Na 2 CO 3 or pyridine, advantageous (method B).
Die Verfahrensprodukte fallen, gegebenenfalls nach Einengen des Lösungsmittels oder Ausfällen mit Wasser, in guten Ausbeuten an und werden nach bekannten Methoden isoliert (siehe Tabelle 1 und 2). Die Strukturen der erhaltenen Umsetzungsprodukte ergeben sich aus den Elementaranalysen, Massen-, 1H- und 13C-NMR-Spektren.The process products are obtained, if appropriate after concentration of the solvent or precipitation with water, in good yields and are isolated by known methods (see Table 1 and 2). The structures of the resulting reaction products are derived from elemental analyzes, mass, 1 H and 13 C NMR spectra.
Ausführungsbeispieleembodiments
Methode AMethod A
lOmmol 2,2-Dimethyl-2,3-dihydro-imidazo[1,2-a]benzimidazol-3-on werden in 10ml Aceton gelöst. Dazu werden bei -7O0C lOmmol Phenylisocyanat getropft. Nach wenigen Minuten schneiden sich weiße Kristalle ab, das Produkt wird abgesaugt und getrocknet. Es werden 80% des S-Phenyl-carbamoyl^-dimethyl^S-dihydro-imidazololi^-albenzimidazol-S-on (2f) (Fp. 178 bis 1800C) isoliert (siehe Tabelle 1).10 mmol of 2,2-dimethyl-2,3-dihydro-imidazo [1,2-a] benzimidazol-3-one are dissolved in 10 ml of acetone. These are added dropwise at -7O 0 C lOmmol phenyl isocyanate. After a few minutes, white crystals cut off, the product is filtered off with suction and dried. There are 80% of the S-phenyl-carbamoyl ^ dimethyl ^ S-dihydro-imidazololi ^ -albenzimidazol-S-one (2f) (mp. 178-180 0 C) was isolated (see Table 1).
Methode BMethod B
lOmmol 2,2-Dimethyl-2,3-dihydro-imidazo[1,2-albenzimidazol-3-on werden in 15ml THF bei 10 bis 150C vorgelegt. Dazu werden lOmmol Kohlensäure-ethylester-chlorid und anschließend lOmmol Triethylamin getropft. Nach einstündigem Rühren bei Raumtemperatur werden 30 ml Wasser addiert, der ausfallende Niederschlag abgesaugt und getrocknet. Es werden 70% 9-Ethoxycarbonyl-2,2-dimethyl-2,3-dihydro-imidazo[1,2-a]benzimidazol-3-on (21) (Fp. 144-1450C) isoliert (siehe Tabelle 1). 6somerisierungen 2 —*> 3lOmmol of 2,2-dimethyl-2,3-dihydro-imidazo [1,2-albenzimidazol be on-3-introduced into 15 ml of THF at 10 to 15 0 C. For this purpose, 10 mmol of carbonic acid ethyl ester chloride and then 10 mmol of triethylamine are added dropwise. After one hour of stirring at room temperature, 30 ml of water are added, the precipitate sucked off and dried. There are 70% 9-ethoxycarbonyl-2,2-dimethyl-2,3-dihydro-imidazo [1,2-a] benzimidazole-3-one (21) (mp. 144-145 0 C) was isolated (see Table 1 ). 6somerizations 2 - *> 3
lOmmol 9-Phenoxycarbonyl-2,2-dimethyl-2,3-dihydro-imidazo[1,2-a]benzimidazol-3-on (2m) werden 24 Stunden in 20ml Aceton bei Raumtemperatur gerührt, das Produkt wird abgesaugt und getrocknet. Es können 84% i-Phenoxycarbonyl-2,2-dimethyl-2,3-dihydro-imidazo[1,2-a]benzimidazol-3-on (3m) erhalten werden (siehe Tabelle 2).10 mmol of 9-phenoxycarbonyl-2,2-dimethyl-2,3-dihydro-imidazo [1,2-a] benzimidazol-3-one (2 ml) are stirred for 24 hours in 20 ml of acetone at room temperature, the product is filtered off with suction and dried. There can be obtained 84% i-phenoxycarbonyl-2,2-dimethyl-2,3-dihydro-imidazo [1,2-a] benzimidazol-3-one (3m) (see Table 2).
1 g 9-Methylcarbomoyl-2,2-dimethyl-2,3-dihydro-imidazo[1,2-a]benzimidazol-3-on (2β) wird in 5 ml DMSO kurz zum Sieden erhitzt. Beim Abkühlen fallen 89% 1-Methylcarbamoyl-2,2-dimethyl-2,3-dihydro-imidazo[1,2-a]benzimidazol-3-on (3e) aus (siehe Tabelle 2).1 g of 9-methylcarbamoyl-2,2-dimethyl-2,3-dihydro-imidazo [1,2-a] benzimidazol-3-one (2β) is briefly boiled in 5 ml of DMSO. Upon cooling, 89% of 1-methylcarbamoyl-2,2-dimethyl-2,3-dihydro-imidazo [1,2-a] benzimidazol-3-one (3e) precipitate (see Table 2).
1 g O-Acotyl^^-dlmothyl^.a-dlhydro-lmldazoII^-nlbonzlmldoiol-a-on (2 b) wird 1 Stundo bei 200°C ohno Lösungsmittel erwärmt. Nach dom Abkühlon wordon 92% i-Acetyl^-dlmothyl^-dihydro-lmldazoli^-albonzlmldazol-S-on (3b) Isollorl {siehe Tabelle 2).1 g O-Acotyl ^^ - dlmothyl ^ .a-dlhydro-lmldazoII ^ -nlbonzlmldoiol-a-on (2 b) is heated for 1 hour at 200 ° C without solvent. After cooling, the product was 92% i-acetyl -dlmothyl-dihydro-imidazolium-alzolmidazol-S-one (3b) iso-norol (see Table 2).
Zu lOmmol 2,2·Dimethyl 2,3·dihγdro·imldazo(1,2·a]benzlmldazol·3-on In 20ml Acetonitril worden bei Raumtemperatur 10mmol 4-Chlorphenyllsocyanat gotropft. Anschließend wird dlo Lösung 10 Minuten zum Sieden orhitzt. Boim Abkühlon fallen 71%1-(4-Chlorphonylcarbomoyl)-2,2-dlmothyl-2,3-dihydro-lmldnzo[1,2-a]bonzlmklQzol-3-on(3l)nus(plohoTabollo2).10 mmol of 4-chlorophenyl phthalocyanate was added dropwise to 20 ml of acetonitrile in 20 ml of acetonitrile at room temperature, then the solution was refluxed for 10 minutes 71% of 1- (4-chloroporonylcarbamoyl) -2,2-dlmothyl-2,3-dihydro-imidnzo [1,2-a] -benzylmkt-3-one (3l) nus (plohoTabollo2).
2l2-Disubstituierte9-Acyl-2,3-dihydro-imidazo[1,2-a]bonzimidazol-3-ono(2a-p) R1 2 l of 2-disubstituted 9-acyl-2,3-dihydro-imidazo [1,2-a] -bonzimidazol-3-oneo (2a-p) R 1
Acylacyl
Ausb. MethodeY. method
Fpfp
(0C)( 0 C)
Summenformol (Molmasse)Total formula (molecular weight)
11 MS-Mol-Peak, bl aus CH3CN, "aus EtOH, "'ausBenzen/Petrolether *' Beim Umkristallisieren findet bereits eine teilweise Isomerisierung zu 3 statt. 11 MS-mole peak, bl out of CH 3 CN, "from EtOH,"'from benzene / petroleum ether *' Recrystallization already leads to a partial isomerization to 3.
Tab. 2 2,2-Disubstituierte1-Acyl-2,3-dihydro-imidazo[1,2-a]benzimidazol-3-one(3a-q)Tab. 2 2,2-Disubstituted 1-acyl-2,3-dihydro-imidazo [1,2-a] benzimidazol-3-ones (3a-q)
R1 R 1
R2 R 2
Acylacyl
Ausb. FpY. fp
(0O( 0 o
SummenformelMolecular formula
(Molmasse"1 (Molecular weight " 1
ber.[gef.])calc. [gef.])
C14H13CI3N4O2 C 14 H 13 Cl 3 N 4 O 2
(375,7)(375.7)
C13H13N3O2 C 13 H 13 N 3 O 2
(243,3/243)(243.3 / 243)
C13H14N4O2 C 13 H 14 N 4 O 2
(258,3/258)(258.3 / 258)
C18H10N4O2 C 18 H 10 N 4 O 2
(320,4)(320.4)
C21H22N4O2 C 21 H 22 N 4 O 2
(362,4)(362.4)
C22H18N4O2 C 22 H 18 N 4 O 2
(370,4)(370.4)
C18H16CIN4O2 C 18 H 16 CIN 4 O 2
(354,8)(354.8)
Fortsetzung Tob.2Continued Tob.2
R1 R 1
R2 R 2
Acyl Ausb.Acyl Ausb.
Fpfp
(1C) (1 C)
SurnmonformolSurnmonformol
(Molmasso"'(Molmasso ''
bor.|gof.|)) |. Bor |. Gof
3| CH3 3 k CH3 2 m CHj3 | CH 3 3k CH 3 2 m CHj
CH3 CH3 CH3 CH 3 CH 3 CH 3
COOCH3 COOC4H6 COOCH 3 COOC 4 H 6
2 ρ -CH2(CHj)3CH2- CONHC6H6 3q -CH2(CHj)3CH2- CONHC6H4-CH(CH3)j-42 ρ -CH 2 (CHj) 3 CH 2 -CONHC 6 H 6 3q -CH 2 (CHj) 3 CH 2 -CONHC 6 H 4 -CH (CH 3 ) j-4
11 MS-Mol-Peak "' aus CH1CN, cl ausDioxan 11 MS mol peak '' from CH 1 CN, cl from dioxane
Formel blattFormula sheet
O R"O R "
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DD33950390A DD293352A5 (en) | 1990-04-06 | 1990-04-06 | PROCESS FOR PREPARING 2,2-DISUBSTITUTED 1-ACYL AND / OR 9-ACYL-2,3-DIHYDRO-IMIDAZO / 1,2-A / BENZIMIDAZOLE-3-ONEN |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DD33950390A DD293352A5 (en) | 1990-04-06 | 1990-04-06 | PROCESS FOR PREPARING 2,2-DISUBSTITUTED 1-ACYL AND / OR 9-ACYL-2,3-DIHYDRO-IMIDAZO / 1,2-A / BENZIMIDAZOLE-3-ONEN |
Publications (1)
Publication Number | Publication Date |
---|---|
DD293352A5 true DD293352A5 (en) | 1991-08-29 |
Family
ID=5617644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD33950390A DD293352A5 (en) | 1990-04-06 | 1990-04-06 | PROCESS FOR PREPARING 2,2-DISUBSTITUTED 1-ACYL AND / OR 9-ACYL-2,3-DIHYDRO-IMIDAZO / 1,2-A / BENZIMIDAZOLE-3-ONEN |
Country Status (1)
Country | Link |
---|---|
DD (1) | DD293352A5 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000050425A1 (en) * | 1999-02-22 | 2000-08-31 | Boehringer Ingelheim Pharmaceuticals, Inc. | Polycyclo heterocyclic derivatives as antiinflammatory agents |
US6333325B1 (en) | 1999-01-19 | 2001-12-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method of treating cytokine mediated diseases or conditions |
US6358945B1 (en) | 1999-03-12 | 2002-03-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compounds useful as anti-inflammatory agents |
US6753426B2 (en) | 1999-07-09 | 2004-06-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | Polymorph and process for preparing same |
-
1990
- 1990-04-06 DD DD33950390A patent/DD293352A5/en not_active IP Right Cessation
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6333325B1 (en) | 1999-01-19 | 2001-12-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method of treating cytokine mediated diseases or conditions |
US6506748B2 (en) | 1999-01-19 | 2003-01-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | Aromatic heterocyclic compounds as antiinflammatory agents |
WO2000050425A1 (en) * | 1999-02-22 | 2000-08-31 | Boehringer Ingelheim Pharmaceuticals, Inc. | Polycyclo heterocyclic derivatives as antiinflammatory agents |
US6242453B1 (en) | 1999-02-22 | 2001-06-05 | Boehringer Ingelheim Pharmaceuticals, Inc | Polycyclo heterocyclic derivatives as antiinflammatory agents |
US6358945B1 (en) | 1999-03-12 | 2002-03-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compounds useful as anti-inflammatory agents |
US6660732B2 (en) | 1999-03-12 | 2003-12-09 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compounds useful as anti-inflammatory agents |
US7019006B2 (en) | 1999-03-12 | 2006-03-28 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compounds useful as anti-inflammatory agents |
US6753426B2 (en) | 1999-07-09 | 2004-06-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | Polymorph and process for preparing same |
US6774233B2 (en) | 1999-07-09 | 2004-08-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents |
US6835832B2 (en) | 1999-07-09 | 2004-12-28 | Boehringer Ingelheim Pharmaceuticals, Inc. | Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents |
US6894173B2 (en) | 1999-07-09 | 2005-05-17 | Boehringer Ingelheim Pharmaceuticals, Inc. | Intermediates useful for synthesis of heteroaryl-substituted urea compounds, and processes of making same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2162096C2 (en) | ||
CH634306A5 (en) | BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND ANTHELMINTIC AGENTS CONTAINING THESE COMPOUNDS AS ACTIVE INGREDIENTS. | |
EP0413226B1 (en) | [1,2,4]Triazo [1,5-a]pyridine | |
DE2259220A1 (en) | CONDENSATION PRODUCTS AND THEIR APPLICATION | |
DE2858737C2 (en) | ||
US4665097A (en) | Novel bicyclooxyaryl thioureas and process for preparation | |
DE2003841B2 (en) | VIRUCIDE AND IMMUNSUPPRESSIVE AGENTS | |
DE2413966A1 (en) | OXAMIC ACID DERIVATIVES | |
DD293352A5 (en) | PROCESS FOR PREPARING 2,2-DISUBSTITUTED 1-ACYL AND / OR 9-ACYL-2,3-DIHYDRO-IMIDAZO / 1,2-A / BENZIMIDAZOLE-3-ONEN | |
DE2845435A1 (en) | METHOD FOR PRODUCING 2,6-DIAMINONEBULARINES | |
CH634307A5 (en) | ANTHELMINTICALLY ACTIVE BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDIUM CONTAINING THESE ACTIVE SUBSTANCES. | |
DE2229248B2 (en) | 5-Iminomethyl-2-nitroimidazole derivatives and process for their preparation | |
DE3151450A1 (en) | N-Phenoxysulphonylureas, their preparation and their use | |
DE2512171A1 (en) | 2,3-DIHALOGEN-ALKANOYL-UREA, METHOD FOR THEIR MANUFACTURE AND THEIR USE AS FUNGICIDES | |
DE1470361C3 (en) | 5,6-Dihydro-6-oxo-pyrido square bracket to 2,3-square bracket to square bracket to 1,4 square bracket to -benzoxazepine and process for its preparation | |
EP0417875B1 (en) | 1-methoxypyrimidinyl-1h-1,2,4-triazole-3-sulfonic acid nitroanilides, process for their preparation and their use as agents with herbicidal activity | |
EP0097614B1 (en) | Pesticides | |
EP0091593A1 (en) | N-pteridinyl ureas, process for their preparation and their use | |
DE1568021C3 (en) | New Isothiocyano diphenylather and diphenylthioather, their produc- tion and means for combating parsi tarer helminths and for preventing helminthiases in humans and animals | |
DE2254474A1 (en) | HYDROXYIMIDAZOLE, THE PROCESS FOR THEIR MANUFACTURING AND PESTICIDES CONTAINING THESE COMPOUNDS | |
DE2624856A1 (en) | Anthelmintic thio-barbituric acid derivs. - have (5)-benzyl-thiocarbamoyl substit. and are esp. useful for control of liver flukes | |
AT312988B (en) | Fungicides | |
DE2428640A1 (en) | ANTHELMINTIC COMPOUNDS AND PROCEDURES FOR THEIR PRODUCTION | |
DE2236339A1 (en) | Alpha-cyano-hydrazones preparation - with pre and post-emergence herbici-dal activity | |
AT358594B (en) | METHOD FOR PRODUCING NEW 2-CYCLO-PROPYLAMINO-4,6-DIAMINO-S-TRIAZINES OR THEIR ACID ADDITION SALTS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENJ | Ceased due to non-payment of renewal fee |